Dr. Sara Boiani
About Dr. Sara Boiani
Dr. Sara Boiani is a Senior Scientist at Adaptimmune, specializing in cancer research with a focus on immunology. She has a robust academic background and extensive experience in biotechnology and molecular biology.
Work at Adaptimmune
Dr. Sara Boiani has been employed as a Senior Scientist at Adaptimmune since 2018. Her role focuses on cancer research, leveraging her expertise in immunology to contribute to the development of innovative therapies. Based in Abingdon, Oxfordshire, United Kingdom, she has been integral to various projects aimed at advancing cell therapy techniques.
Previous Experience in Research
Prior to her current position, Dr. Boiani worked as a Scientist at the Max Delbrück Center from 2013 to 2016 in Berlin, Germany. She also served as a volunteer researcher at the Ramazzini Institute in 2012 and held the position of Science Assistant at The Babraham Institute from 2012 to 2013 in Cambridge, United Kingdom. These roles provided her with a diverse range of experiences in the field of biological research.
Education and Expertise
Dr. Boiani earned her Doctorate in Biology/Molecular Immunology from Freie Universität Berlin, completing her studies from 2014 to 2019. She also holds a Master of Science in Medical Biotechnology from Alma Mater Studiorum – Università di Bologna, obtained between 2009 and 2011, and a Bachelor of Science in Biotechnology from Università di Bologna, completed from 2006 to 2009. Her educational background underpins her deep understanding of immunology and molecular and cellular biology.
Specialized Skills in Data Analysis
Dr. Boiani possesses expertise in R data analysis, a skill that is not commonly highlighted in the biotechnology industry. This proficiency enhances her research capabilities, particularly in analyzing complex biological data, which is essential for her work in cancer research and cell therapy.
Background in Molecular & Cellular Biology
Dr. Boiani has a strong background in Molecular & Cellular Biology, which significantly contributes to her role in cell therapy research at Adaptimmune. Her foundational knowledge in these areas supports her efforts in developing effective cancer treatment strategies.